{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T16:25:04Z","timestamp":1791563104469,"version":"4.3.4"},"reference-count":60,"publisher":"Oxford University Press (OUP)","issue":"3","content-domain":{"domain":["eje.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2016,3]]},"abstract":"<jats:p>GnRH analogues (GnRHa) are the treatment of choice for central precocious puberty (CPP), with the main objective to recover the height potential compromised by the premature fusion of growth cartilages. The aim of this review was to analyze long-term effects of GnRHa on height, body weight, reproductive function, and bone mineral density (BMD) in patients with CPP, as well as the potential predictors of outcome. Because randomized controlled trials on the effectiveness and long-term outcomes of treatment are not available, only qualified conclusions about the efficacy of interventions can be drawn. GnRHa treatment appears to improve adult height in girls with CPP, especially if diagnosed before the age of 6, whereas a real benefit in terms of adult height is still controversial in patients with the onset of puberty between 6 and 8 years of age. No height benefit was shown in patients treated after 8 years. Gonadal function is promptly restored in girls after cessation of treatment, and reproductive potential appears normal in young adulthood. Data are conflicting on the long-term risk of polycystic ovarian syndrome in both treated and untreated women. Fat mass is increased at the start of treatment but normalizes thereafter, and GnRHa itself does not seem to have any long-term effect on BMI. Similarly, analogue treatment does not appear to have a negative impact on BMD. Owing to the paucity of data available, no conclusions can be drawn on the repercussions of CPP and\/or its treatment on the timing of menopause and on the health of the offspring.<\/jats:p>","DOI":"10.1530\/eje-15-0590","type":"journal-article","created":{"date-parts":[[2016,1,16]],"date-time":"2016-01-16T17:23:19Z","timestamp":1452964999000},"page":"R79-R87","update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-1","source":"Crossref","is-referenced-by-count":125,"title":["MANAGEMENT OF ENDOCRINE DISEASE: Long-term outcomes of the treatment of central precocious puberty"],"prefix":"10.1093","volume":"174","author":[{"given":"Federica","family":"Guaraldi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guglielmo","family":"Beccuti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Gori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Ghizzoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","reference":[{"key":"2016011518231042000_174.3.R79.1","doi-asserted-by":"publisher","DOI":"10.1210\/er.22.1.111"},{"key":"2016011518231042000_174.3.R79.2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp0800459"},{"key":"2016011518231042000_174.3.R79.3","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.paed.2007.06.009","article-title":"Precocious puberty","volume":"17","author":"Dixon","year":"2007","journal-title":"Paediatrics and Child Health"},{"key":"2016011518231042000_174.3.R79.4","doi-asserted-by":"publisher","DOI":"10.1159\/000366282"},{"key":"2016011518231042000_174.3.R79.5","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2012-3773"},{"key":"2016011518231042000_174.3.R79.6","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/j.1745-7262.2008.00409.x","article-title":"Treatment of central precocious puberty by GnRH analogs: long-term outcome in men","volume":"10","author":"Bertelloni","year":"2008","journal-title":"Asian Journal of Andrology"},{"key":"2016011518231042000_174.3.R79.7","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2008-1783"},{"key":"2016011518231042000_174.3.R79.8","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmh012"},{"key":"2016011518231042000_174.3.R79.9","doi-asserted-by":"publisher","DOI":"10.1515\/JPEM.2000.13.S1.723"},{"key":"2016011518231042000_174.3.R79.10","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1442-2042.2011.02886.x","article-title":"Life-threatening anaphylaxis to leuprorelin acetate depot: case report and review of the literature","volume":"19","author":"Fujisaki","year":"2012","journal-title":"International Journal of Urology"},{"key":"2016011518231042000_174.3.R79.11","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.ecl.2012.08.003","article-title":"Pubertal disorders and bone maturation","volume":"41","author":"Lazar","year":"2012","journal-title":"Endocrinology and Metabolism Clinics of North America"},{"key":"2016011518231042000_174.3.R79.12","doi-asserted-by":"publisher","DOI":"10.1210\/jc.84.6.1973"},{"key":"2016011518231042000_174.3.R79.13","doi-asserted-by":"publisher","DOI":"10.1080\/08035259850158227"},{"key":"2016011518231042000_174.3.R79.14","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.2002.01488.x"},{"key":"2016011518231042000_174.3.R79.15","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2007-1216"},{"key":"2016011518231042000_174.3.R79.16","doi-asserted-by":"publisher","DOI":"10.3109\/09513590.2010.507289"},{"key":"2016011518231042000_174.3.R79.17","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2007-0321"},{"key":"2016011518231042000_174.3.R79.18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000063209","article-title":"Effect of gonadotropin-releasing hormone agonist treatment in boys with central precocious puberty: final height results","volume":"58","author":"Mul","year":"2002","journal-title":"Hormone Research"},{"key":"2016011518231042000_174.3.R79.19","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2004-1863"},{"key":"2016011518231042000_174.3.R79.20","doi-asserted-by":"publisher","DOI":"10.1530\/eje.0.1410140"},{"key":"2016011518231042000_174.3.R79.21","first-page":"633","article-title":"Long-acting GnRH analogue triptorelin therapy in central isosexual precocious puberty","volume":"39","author":"Bajpai","year":"2002","journal-title":"Indian Pediatrics"},{"key":"2016011518231042000_174.3.R79.22","doi-asserted-by":"publisher","DOI":"10.1210\/jc.84.12.4583"},{"key":"2016011518231042000_174.3.R79.23","doi-asserted-by":"crossref","first-page":"214","DOI":"10.6065\/apem.2014.19.4.214","article-title":"Adult height in girls with central precocious puberty treated with gonadotropin-releasing hormone agonist with or without growth hormone","volume":"19","author":"Jung","year":"2014","journal-title":"Annals of Pediatric Endocrinology & Metabolism"},{"key":"2016011518231042000_174.3.R79.24","doi-asserted-by":"publisher","DOI":"10.1210\/jc.86.10.4711"},{"key":"2016011518231042000_174.3.R79.25","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1515\/jpem-2014-0305","article-title":"Effect of GnRHa 3.75\u200amg subcutaneously every 6 weeks on adult height in girls with idiopathic central precocious puberty","volume":"28","author":"Liang","year":"2015","journal-title":"Journal of Pediatric Endocrinology and Metabolism"},{"key":"2016011518231042000_174.3.R79.26","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1159\/000185432","article-title":"Final height of girls with central precocious puberty, untreated versus treated with cyproterone acetate or GnRH analogue. A comparative study with re-evaluation of predictions by the Bayley\u2013Pinneau method","volume":"47","author":"Kauli","year":"1997","journal-title":"Hormone Research"},{"key":"2016011518231042000_174.3.R79.27","doi-asserted-by":"publisher","DOI":"10.1007\/s004310050831"},{"key":"2016011518231042000_174.3.R79.28","doi-asserted-by":"publisher","DOI":"10.1067\/mpd.2000.109201"},{"key":"2016011518231042000_174.3.R79.29","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1515\/JPEM.2009.22.4.309","article-title":"Normal adult height among girls treated for central precocious puberty with gonadotropin-releasing hormone analog therapy","volume":"22","author":"Nabhan","year":"2009","journal-title":"Journal of Pediatric Endocrinology & Metabolism"},{"key":"2016011518231042000_174.3.R79.30","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2007-2183"},{"key":"2016011518231042000_174.3.R79.31","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.jpeds.2013.01.021","article-title":"Time to menarche and final height after histrelin implant treatment for central precocious puberty","volume":"163","author":"Gillis","year":"2013","journal-title":"Journal of Pediatrics"},{"key":"2016011518231042000_174.3.R79.32","doi-asserted-by":"publisher","DOI":"10.1159\/000231994"},{"key":"2016011518231042000_174.3.R79.33","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1515\/JPEM.2006.19.11.1327","article-title":"Weight evolution in girls treated for idiopathic central precocious puberty with GnRH analogues","volume":"19","author":"Aguiar","year":"2006","journal-title":"Journal of Pediatric Endocrinology & Metabolism"},{"key":"2016011518231042000_174.3.R79.34","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/nrendo.2011.241","article-title":"Effects of obesity on human sexual development","volume":"8","author":"Wagner","year":"2012","journal-title":"Nature Reviews. Endocrinology"},{"key":"2016011518231042000_174.3.R79.35","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1210\/jc.2014-3748","article-title":"Treated and untreated women with idiopathic precocious puberty: BMI evolution, metabolic outcome, and general health between third and fifth decades","volume":"100","author":"Lazar","year":"2015","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"2016011518231042000_174.3.R79.36","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2009-0793"},{"key":"2016011518231042000_174.3.R79.37","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1159\/000346145","article-title":"Treatment with gonadotropin-releasing hormone analogues: different impact on body weight in normal-weight and overweight children","volume":"78","author":"Wolters","year":"2012","journal-title":"Hormone Research in Paediatrics"},{"key":"2016011518231042000_174.3.R79.38","doi-asserted-by":"publisher","DOI":"10.1210\/jc.87.2.506"},{"key":"2016011518231042000_174.3.R79.39","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1687-9856-2014-5","article-title":"Higher prevalence of obesity and overweight without an adverse metabolic profile in girls with central precocious puberty compared to girls with early puberty, regardless of GnRH analogue treatment","volume":"2014","author":"Colmenares","year":"2014","journal-title":"International Journal of Pediatric Endocrinology"},{"key":"2016011518231042000_174.3.R79.40","doi-asserted-by":"publisher","DOI":"10.1210\/jc.84.1.44"},{"key":"2016011518231042000_174.3.R79.41","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2004.02146.x"},{"key":"2016011518231042000_174.3.R79.42","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.jpeds.2013.12.009","article-title":"Resumption of puberty in girls and boys following removal of the histrelin implant","volume":"164","author":"Fisher","year":"2014","journal-title":"Journal of Pediatrics"},{"key":"2016011518231042000_174.3.R79.43","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-3031"},{"key":"2016011518231042000_174.3.R79.44","doi-asserted-by":"publisher","DOI":"10.1210\/jc.75.3.890"},{"key":"2016011518231042000_174.3.R79.45","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1111\/cen.12319","article-title":"Treated and untreated women with idiopathic precocious puberty: long-term follow-up and reproductive outcome between the third and fifth decades","volume":"80","author":"Lazar","year":"2014","journal-title":"Clinical Endocrinology"},{"key":"2016011518231042000_174.3.R79.46","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/j.1365-2265.1995.tb01853.x","article-title":"Ovaries in sexual precocity","volume":"42","author":"Bridges","year":"1995","journal-title":"Clinical Endocrinology"},{"key":"2016011518231042000_174.3.R79.47","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(98)70493-7"},{"key":"2016011518231042000_174.3.R79.48","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2008.11.016"},{"key":"2016011518231042000_174.3.R79.49","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2006.05.026"},{"key":"2016011518231042000_174.3.R79.50","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.mce.2006.04.012","article-title":"Long-term GnRH agonist treatment for female central precocious puberty does not impair reproductive function","volume":"254\u2013255","author":"Heger","year":"2006","journal-title":"Molecular and Cellular Endocrinology"},{"key":"2016011518231042000_174.3.R79.51","doi-asserted-by":"publisher","DOI":"10.1136\/adc.75.4.292"},{"key":"2016011518231042000_174.3.R79.52","doi-asserted-by":"crossref","first-page":"398639","DOI":"10.1186\/1687-9856-2010-398639","article-title":"Leuprolide acetate 1-month depot for central precocious puberty: hormonal suppression and recovery","volume":"2010","author":"Neely","year":"2010","journal-title":"International Journal of Pediatric Endocrinology"},{"key":"2016011518231042000_174.3.R79.53","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.1999.00886.x"},{"key":"2016011518231042000_174.3.R79.54","doi-asserted-by":"publisher","DOI":"10.1210\/jc.85.11.4036"},{"key":"2016011518231042000_174.3.R79.55","doi-asserted-by":"publisher","DOI":"10.1007\/s004310051289"},{"key":"2016011518231042000_174.3.R79.56","doi-asserted-by":"publisher","DOI":"10.1210\/jc.83.2.370"},{"key":"2016011518231042000_174.3.R79.57","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2012.04418.x"},{"key":"2016011518231042000_174.3.R79.58","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1515\/jpem.2011.170","article-title":"Evaluation of bone density in girls with precocious and early puberty during treatment with GnRH agonist","volume":"24","author":"Assa","year":"2011","journal-title":"Journal of Pediatric Endocrinology & Metabolism"},{"key":"2016011518231042000_174.3.R79.59","doi-asserted-by":"crossref","first-page":"591","DOI":"10.6061\/clinics\/2012(06)08","article-title":"Bone mineral density and body composition in girls with idiopathic central precocious puberty before and after treatment with a gonadotropin-releasing hormone agonist","volume":"67","author":"Alessandri","year":"2012","journal-title":"Clinics"},{"key":"2016011518231042000_174.3.R79.60","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/S0929-6646(08)60047-9","article-title":"The effects of gonadotropin releasing hormone analogue therapy on girls with gonadotropin-dependent precocious puberty","volume":"106","author":"Tung","year":"2007","journal-title":"Journal of the Formosan Medical Association"}],"container-title":["European Journal of Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/eje.bioscientifica.com\/view\/journals\/eje\/174\/3\/R79.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/eje.bioscientifica.com\/view\/journals\/eje\/174\/3\/R79.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T16:33:03Z","timestamp":1676392383000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ejendo\/article\/174\/3\/R79\/6655514"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":60,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.1530\/eje-15-0590","relation":{},"ISSN":["0804-4643","1479-683X"],"issn-type":[{"value":"0804-4643","type":"print"},{"value":"1479-683X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3]]}}}